Current free positions

Radiochemisch analist (36 uur)
Medewerker administratie (36 uur)
Manager QA / QP (36 uur)

Please note:

We are generally looking for candidates who master the Dutch language.

We vragen over het algemeen mensen die de Nederlandse taal uitstekend beheersen, omdat de meeste documentatie in ons bedrijf in het Nederlands is.

Last update: 24.02.18

+31 20 44 49 123

Fact Sheets

Iodine-124
Zirconium-89
Fluoromethylcholine (¹⁸F)
Sodium Iodide (¹²⁴I)
[¹⁸F]Florbetaben (Neuraceq)
FDG (¹⁸F)
⁸¹Rb₈₁mKr Generator
Transport Container: Lead Transport Container: Tungsten
Zirconium-89 training

GMP-certificate

See all details about our GMP-certificate, issued june 2016 and re-issued 2018 by the Health Care Inspectorate for Pharmaceutical Affairs and Medical Technology.

Twitter

14.2.2017 14:52

Tomorrow, our managing director will give a talk at the molecular imaging conference in Groningen https://t.co/771CTQhVvR

19.9.2016 11:24

Research from the university of Duisburg shows high level of agreement between 124I-PET and 131I-imaging https://t.co/OGzYsMSMiN

1.8.2016 10:41

We are hiring! Two new interesting job postings: https://t.co/YtJf4ojKMS

Featured Articles

Van Dongen, G. A., M. C. Huisman, R. Boellaard, Hendrikse N. Harry, A. D. Windhorst, G. W. Visser, C. F. Molthoff, and D. J. Vugts. “89Zr-immuno-PET for imaging of long circulating drugs and disease targets: why, how and when to be applied?.” The quarterly journal of nuclear medicine and molecular imaging: official publication of the Italian Association of Nuclear Medicine (AIMN)[and] the International Association of Radiopharmacology (IAR),[and] Section of the Society of.. 59, no. 1 (2015): 18-38.

Villemagne VL, Mulligan RS, Pejoska S, Ong K, Jones G, O’Keefe G, Chan JG, Young K, Tochon-Danguy H, Masters CL, Rowe CC, Comparison of ¹¹C-PiB and ¹⁸F-florbetaben for Aß imaging in ageing and Alzheimer’s disease, Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):983-9. Epub 2012 Mar 8.

Rizvi SN, Visser OJ, Vosjan MJ, van Lingen A, Hoekstra OS, Zijlstra JM, Huijgens PC, van Dongen GA, Lubberink M. Biodistribution, radiation dosimetry and scouting of (90)Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using (89)Zr-ibritumomab tiuxetan and PET. Eur J Nucl Med Mol Imaging. 2012 Jan 5. (Epub ahead of print)

Have you spotted relevant or interesting new research? Let us know!